ici 118551 has been researched along with Benign Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolusić, E | 1 |
| Larrieu, P | 1 |
| Moineaux, L | 1 |
| Stroobant, V | 1 |
| Pilotte, L | 1 |
| Colau, D | 1 |
| Pochet, L | 1 |
| Van den Eynde, B | 1 |
| Masereel, B | 1 |
| Wouters, J | 1 |
| Frédérick, R | 1 |
1 other study available for ici 118551 and Benign Neoplasms
| Article | Year |
|---|---|
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Drug Design; Enzyme Inhibitors; | 2011 |